Patents Assigned to Savient Pharmaceuticals, Inc.
  • Fibrin binding domain polypeptides and uses and methods of producing same
    Patent number: 7087722
    Abstract: This invention provides an imaging agent which comprises a polypeptide labeled with an imageable marker, such polypeptide having an amino acid sequence substantially present in the fibrin binding domain of naturally-occurring human fibronectin and being capable of binding to fibrin. The invention further provides a method wherein the imaging agent is used for imaging a fibrin-containing substance, i.e., a thrombus or atherosclerotic plaque. Further provided are plasmids for expression of polypeptides having an amino acid sequence substantially present in the fibrin binding domain of naturally-occurring human fibronectin and being capable of binding to fibrin, hosts containing these plasmids, methods of producing the polypeptides, methods of treatment using the polypeptides, and methods of recovering, refolding and reoxidizing the polypeptides.
    Type: Grant
    Filed: January 27, 2000
    Date of Patent: August 8, 2006
    Assignee: Savient Pharmaceuticals, Inc.
    Inventors: Tikva Vogel, Avigdor Levanon, Moshe Werber, Rachel Guy, Amos Panet
  • Use of oxandrolone in the treatment of burns and other wounds
    Patent number: 6828313
    Abstract: The subject invention provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The invention also provides a method of treating a wound in a patient suffering from a wound which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The subject invention further provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone in conjunction with a protein supplement to the patient.
    Type: Grant
    Filed: October 22, 2001
    Date of Patent: December 7, 2004
    Assignee: Savient Pharmaceuticals, Inc.
    Inventor: Don Fishbein
  • Use of oxandrolone in the treatment of burns and other wounds
    Publication number: 20040235940
    Abstract: The subject invention provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The invention also provides a method of treating a wound in a patient suffering from a wound which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The subject invention further provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone in conjunction with a protein supplement to the patient.
    Type: Application
    Filed: March 12, 2004
    Publication date: November 25, 2004
    Applicant: Savient Pharmaceuticals, Inc.
    Inventor: Don Fishbein
  • Use of oxandrolone in the treatment of burns and other wounds
    Publication number: 20040171673
    Abstract: The subject invention provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The invention also provides a method of treating a wound in a patient suffering from a wound which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The subject invention further provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone in conjunction with a protein supplement to the patient.
    Type: Application
    Filed: March 12, 2004
    Publication date: September 2, 2004
    Applicant: Savient Pharmaceuticals, Inc.
    Inventor: Don Fishbein